{
    "info": {
        "nct_id": "NCT03889795",
        "official_title": "Phase IB Trial of Metformin, Digoxin, Simvastatin in Subjects with Advanced Pancreatic Cancer and Other Advanced Solid Tumors",
        "inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Anti-cancer chemotherapy, biologic therapy or immunotherapy within 3 weeks or radiation therapy within 2 weeks of first infusion.\n2. Known history of other malignancy unless having undergone curative intent therapy without evidence of that disease for ≥ 3 years except cutaneous squamous cell and basal cell skin cancer, superficial bladder cancer, in situ cervical cancer or other in situ cancers are allowed if definitively resected.\n3. Patients with only PET non-avid disease.\n4. Brain metastases unless treated with curative intent (gamma knife or surgical resection) and without evidence of progression for ≥ 2 months.\n5. Known history of rhabdomyolysis.\n6. History of or current evidence of any condition (including medical, psychiatric or substance abuse disorder), therapy, or laboratory abnormality that might confound the results of the study, interfere with the subject's participation for the full duration of the study, or is not in the best interest of the subject to participate, in the opinion of the Investigator.\n7. Known HIV or chronic Hepatitis B or C infection.\n8. Have signs and symptoms consistent with an active infection.\n9. Live vaccination for the prevention of infectious disease administered <30 days prior to the start of study therapy or inactivated vaccination <14 days prior to the start of study therapy.\n10. History of severe allergic, anaphylactic, or other hypersensitivity reactions to Metformin, Simvastatin, and/or Digoxin.\n11. Patients diagnosed with Wolff-Parkinson-White Syndrome or electrocardiographic (ECG) pattern. Other cardiac conditions including: Previous MI with evidence of residual electrographic pattern consisted with bradycardia/heart block. Atrio-ventricular (AV) heart block (currently ongoing). History of ventricular fibrillation. Sick Sinus Syndrome or Sinus bradycardia thought to be caused by sinus node disease, unless effectively treated. Heart failure associated with preserved left ventricular ejection fraction, including constructive pericarditis, restrictive cardiomyopathy, and Amyloid heart muscle disease.\n12. Women of childbearing potential who are found to be pregnant as evidenced by positive serum pregnancy test (minimum sensitivity 25 IU/L or equivalent units of HCG) or nursing.",
        "miscellaneous_criteria": "Inclusion Criteria\n\n1. Subject ≥18 years with histologically confirmed solid tumor.\n2. Dose expansion subjects must have at least one tumor mass amenable to core needle biopsy.\n3. Refractory or intolerant to established standard of care.\n4. Have at least one tumor mass amenable to core needle biopsy. Adequate Archival Tissue required for patients that will take part in the dose escalation cohorts.\n5. ECOG performance status (PS) = 0-2, or Karnofsky PS ≥60%, or Lansky PS ≥60%.\n6. Normal organ and marrow function: absolute granulocyte count ≥1,000/mm3, absolute lymphocyte count ≥400/mm3, platelets ≥100,000/mm3, total bilirubin ≤ institutional upper normal limit, AST/ASL ≤2x institutional upper limit of normal, GFR >60 mL/min/1.73 m2 and creatinine <1.5 mg/dL.\n7. Subject has recovered to CTCAE Grade 1 or better from all adverse events associated with prior therapy or surgery. Pre-existing motor or sensory neurologic pathology or symptoms must be recovered to CTCAE Grade 2 or better.\n8. If female of childbearing potential, has a negative urine or serum pregnancy test. If the urine test is positive or cannot be confirmed as negative, a negative serum test will then be required for study entry.\n9. Ability to understand and the willingness to sign a written informed protocol specific consent."
    },
    "inclusion_lines": [
        {
            "identified_line": {
                "line": "Healthy volunteers allowed",
                "criterions": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must have minimum age of 18 Years",
                "criterions": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            }
        }
    ],
    "exclusion_lines": [
        {
            "identified_line": {
                "line": "6. History of or current evidence of any condition (including medical, psychiatric or substance abuse disorder), therapy, or laboratory abnormality that might confound the results of the study, interfere with the subject's participation for the full duration of the study, or is not in the best interest of the subject to participate, in the opinion of the Investigator.",
                "criterions": [
                    {
                        "exact_snippets": "History of or current evidence of any condition (including medical, psychiatric or substance abuse disorder)",
                        "criterion": "medical, psychiatric, or substance abuse disorder",
                        "requirement": {
                            "requirement_type": "history or current evidence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "therapy",
                        "criterion": "therapy",
                        "requirement": {
                            "requirement_type": "history or current evidence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "laboratory abnormality",
                        "criterion": "laboratory abnormality",
                        "requirement": {
                            "requirement_type": "history or current evidence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "History of or current evidence of any condition (including medical, psychiatric or substance abuse disorder)",
                        "criterion": "medical, psychiatric, or substance abuse disorder",
                        "requirement": {
                            "requirement_type": "history or current evidence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "therapy",
                        "criterion": "therapy",
                        "requirement": {
                            "requirement_type": "history or current evidence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "laboratory abnormality",
                        "criterion": "laboratory abnormality",
                        "requirement": {
                            "requirement_type": "history or current evidence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "12. Women of childbearing potential who are found to be pregnant as evidenced by positive serum pregnancy test (minimum sensitivity 25 IU/L or equivalent units of HCG) or nursing.",
                "criterions": [
                    {
                        "exact_snippets": "Women of childbearing potential who are found to be pregnant as evidenced by positive serum pregnancy test",
                        "criterion": "pregnancy status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "positive serum pregnancy test (minimum sensitivity 25 IU/L or equivalent units of HCG)",
                        "criterion": "serum pregnancy test result",
                        "requirement": {
                            "requirement_type": "result",
                            "expected_value": "positive"
                        }
                    },
                    {
                        "exact_snippets": "positive serum pregnancy test (minimum sensitivity 25 IU/L or equivalent units of HCG)",
                        "criterion": "serum pregnancy test result",
                        "requirement": {
                            "requirement_type": "test_sensitivity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 25,
                                "unit": "IU/L"
                            }
                        }
                    },
                    {
                        "exact_snippets": "nursing",
                        "criterion": "nursing status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "Women of childbearing potential who are found to be pregnant as evidenced by positive serum pregnancy test",
                                        "criterion": "pregnancy status",
                                        "requirement": {
                                            "requirement_type": "presence",
                                            "expected_value": true
                                        }
                                    },
                                    {
                                        "exact_snippets": "positive serum pregnancy test (minimum sensitivity 25 IU/L or equivalent units of HCG)",
                                        "criterion": "serum pregnancy test result",
                                        "requirement": {
                                            "requirement_type": "result",
                                            "expected_value": "positive"
                                        }
                                    },
                                    {
                                        "exact_snippets": "positive serum pregnancy test (minimum sensitivity 25 IU/L or equivalent units of HCG)",
                                        "criterion": "serum pregnancy test result",
                                        "requirement": {
                                            "requirement_type": "test_sensitivity",
                                            "expected_value": {
                                                "operator": ">=",
                                                "value": 25,
                                                "unit": "IU/L"
                                            }
                                        }
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "exact_snippets": "nursing",
                        "criterion": "nursing status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "1. Anti-cancer chemotherapy, biologic therapy or immunotherapy within 3 weeks or radiation therapy within 2 weeks of first infusion.",
                "criterions": [
                    {
                        "exact_snippets": "Anti-cancer chemotherapy ... within 3 weeks of first infusion.",
                        "criterion": "anti-cancer chemotherapy",
                        "requirement": {
                            "requirement_type": "time since last treatment",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "weeks"
                            }
                        }
                    },
                    {
                        "exact_snippets": "biologic therapy or immunotherapy within 3 weeks of first infusion.",
                        "criterion": "biologic therapy or immunotherapy",
                        "requirement": {
                            "requirement_type": "time since last treatment",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "weeks"
                            }
                        }
                    },
                    {
                        "exact_snippets": "radiation therapy within 2 weeks of first infusion.",
                        "criterion": "radiation therapy",
                        "requirement": {
                            "requirement_type": "time since last treatment",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "not_criteria": {
                            "exact_snippets": "Anti-cancer chemotherapy ... within 3 weeks of first infusion.",
                            "criterion": "anti-cancer chemotherapy",
                            "requirement": {
                                "requirement_type": "time since last treatment",
                                "expected_value": {
                                    "operator": ">=",
                                    "value": 3,
                                    "unit": "weeks"
                                }
                            }
                        }
                    },
                    {
                        "not_criteria": {
                            "exact_snippets": "biologic therapy or immunotherapy within 3 weeks of first infusion.",
                            "criterion": "biologic therapy or immunotherapy",
                            "requirement": {
                                "requirement_type": "time since last treatment",
                                "expected_value": {
                                    "operator": ">=",
                                    "value": 3,
                                    "unit": "weeks"
                                }
                            }
                        }
                    },
                    {
                        "not_criteria": {
                            "exact_snippets": "radiation therapy within 2 weeks of first infusion.",
                            "criterion": "radiation therapy",
                            "requirement": {
                                "requirement_type": "time since last treatment",
                                "expected_value": {
                                    "operator": ">=",
                                    "value": 2,
                                    "unit": "weeks"
                                }
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "8. Have signs and symptoms consistent with an active infection.",
                "criterions": [
                    {
                        "exact_snippets": "signs and symptoms consistent with an active infection",
                        "criterion": "active infection",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "signs and symptoms consistent with an active infection",
                    "criterion": "active infection",
                    "requirement": {
                        "requirement_type": "presence",
                        "expected_value": true
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "3. Patients with only PET non-avid disease.",
                "criterions": [
                    {
                        "exact_snippets": "only PET non-avid disease",
                        "criterion": "disease PET avidity",
                        "requirement": {
                            "requirement_type": "PET avidity",
                            "expected_value": "non-avid"
                        }
                    },
                    {
                        "exact_snippets": "only PET non-avid disease",
                        "criterion": "disease PET avidity",
                        "requirement": {
                            "requirement_type": "exclusivity",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "only PET non-avid disease",
                        "criterion": "disease PET avidity",
                        "requirement": {
                            "requirement_type": "PET avidity",
                            "expected_value": "non-avid"
                        }
                    },
                    {
                        "exact_snippets": "only PET non-avid disease",
                        "criterion": "disease PET avidity",
                        "requirement": {
                            "requirement_type": "exclusivity",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "9. Live vaccination for the prevention of infectious disease administered <30 days prior to the start of study therapy or inactivated vaccination <14 days prior to the start of study therapy.",
                "criterions": [
                    {
                        "exact_snippets": "Live vaccination for the prevention of infectious disease administered <30 days prior to the start of study therapy",
                        "criterion": "live vaccination for the prevention of infectious disease",
                        "requirement": {
                            "requirement_type": "administration timing",
                            "expected_value": {
                                "operator": "<",
                                "value": 30,
                                "unit": "days prior to the start of study therapy"
                            }
                        }
                    },
                    {
                        "exact_snippets": "inactivated vaccination <14 days prior to the start of study therapy",
                        "criterion": "inactivated vaccination",
                        "requirement": {
                            "requirement_type": "administration timing",
                            "expected_value": {
                                "operator": "<",
                                "value": 14,
                                "unit": "days prior to the start of study therapy"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Live vaccination for the prevention of infectious disease administered <30 days prior to the start of study therapy",
                        "criterion": "live vaccination for the prevention of infectious disease",
                        "requirement": {
                            "requirement_type": "administration timing",
                            "expected_value": {
                                "operator": "<",
                                "value": 30,
                                "unit": "days prior to the start of study therapy"
                            }
                        }
                    },
                    {
                        "exact_snippets": "inactivated vaccination <14 days prior to the start of study therapy",
                        "criterion": "inactivated vaccination",
                        "requirement": {
                            "requirement_type": "administration timing",
                            "expected_value": {
                                "operator": "<",
                                "value": 14,
                                "unit": "days prior to the start of study therapy"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "7. Known HIV or chronic Hepatitis B or C infection.",
                "criterions": [
                    {
                        "exact_snippets": "Known HIV ... infection",
                        "criterion": "HIV infection",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "chronic Hepatitis B ... infection",
                        "criterion": "chronic Hepatitis B infection",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "chronic Hepatitis ... C infection",
                        "criterion": "chronic Hepatitis C infection",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Known HIV ... infection",
                        "criterion": "HIV infection",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "chronic Hepatitis B ... infection",
                        "criterion": "chronic Hepatitis B infection",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "chronic Hepatitis ... C infection",
                        "criterion": "chronic Hepatitis C infection",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "5. Known history of rhabdomyolysis.",
                "criterions": [
                    {
                        "exact_snippets": "Known history of rhabdomyolysis",
                        "criterion": "rhabdomyolysis",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Known history of rhabdomyolysis",
                    "criterion": "rhabdomyolysis",
                    "requirement": {
                        "requirement_type": "history",
                        "expected_value": true
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "10. History of severe allergic, anaphylactic, or other hypersensitivity reactions to Metformin, Simvastatin, and/or Digoxin.",
                "criterions": [
                    {
                        "exact_snippets": "History of severe allergic, anaphylactic, or other hypersensitivity reactions to Metformin",
                        "criterion": "hypersensitivity reactions to Metformin",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "History of severe allergic, anaphylactic, or other hypersensitivity reactions to Metformin",
                        "criterion": "hypersensitivity reactions to Metformin",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        }
                    },
                    {
                        "exact_snippets": "History of severe allergic, anaphylactic, or other hypersensitivity reactions to ... Simvastatin",
                        "criterion": "hypersensitivity reactions to Simvastatin",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "History of severe allergic, anaphylactic, or other hypersensitivity reactions to ... Simvastatin",
                        "criterion": "hypersensitivity reactions to Simvastatin",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        }
                    },
                    {
                        "exact_snippets": "History of severe allergic, anaphylactic, or other hypersensitivity reactions to ... Digoxin",
                        "criterion": "hypersensitivity reactions to Digoxin",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "History of severe allergic, anaphylactic, or other hypersensitivity reactions to ... Digoxin",
                        "criterion": "hypersensitivity reactions to Digoxin",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "History of severe allergic, anaphylactic, or other hypersensitivity reactions to Metformin",
                                "criterion": "hypersensitivity reactions to Metformin",
                                "requirement": {
                                    "requirement_type": "history",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "History of severe allergic, anaphylactic, or other hypersensitivity reactions to Metformin",
                                "criterion": "hypersensitivity reactions to Metformin",
                                "requirement": {
                                    "requirement_type": "severity",
                                    "expected_value": "severe"
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "History of severe allergic, anaphylactic, or other hypersensitivity reactions to ... Simvastatin",
                                "criterion": "hypersensitivity reactions to Simvastatin",
                                "requirement": {
                                    "requirement_type": "history",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "History of severe allergic, anaphylactic, or other hypersensitivity reactions to ... Simvastatin",
                                "criterion": "hypersensitivity reactions to Simvastatin",
                                "requirement": {
                                    "requirement_type": "severity",
                                    "expected_value": "severe"
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "History of severe allergic, anaphylactic, or other hypersensitivity reactions to ... Digoxin",
                                "criterion": "hypersensitivity reactions to Digoxin",
                                "requirement": {
                                    "requirement_type": "history",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "History of severe allergic, anaphylactic, or other hypersensitivity reactions to ... Digoxin",
                                "criterion": "hypersensitivity reactions to Digoxin",
                                "requirement": {
                                    "requirement_type": "severity",
                                    "expected_value": "severe"
                                }
                            }
                        ]
                    }
                ]
            }
        }
    ],
    "miscellaneous_lines": [
        {
            "identified_line": {
                "line": "4. Have at least one tumor mass amenable to core needle biopsy. Adequate Archival Tissue required for patients that will take part in the dose escalation cohorts.",
                "criterions": [
                    {
                        "exact_snippets": "at least one tumor mass amenable to core needle biopsy",
                        "criterion": "tumor mass",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "mass"
                            }
                        }
                    },
                    {
                        "exact_snippets": "at least one tumor mass amenable to core needle biopsy",
                        "criterion": "tumor mass",
                        "requirement": {
                            "requirement_type": "amenability to core needle biopsy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate Archival Tissue required for patients that will take part in the dose escalation cohorts",
                        "criterion": "archival tissue",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate Archival Tissue required for patients that will take part in the dose escalation cohorts",
                        "criterion": "archival tissue",
                        "requirement": {
                            "requirement_type": "requirement for patients that will take part in the dose escalation cohorts",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "at least one tumor mass amenable to core needle biopsy",
                                "criterion": "tumor mass",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": "mass"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "at least one tumor mass amenable to core needle biopsy",
                                "criterion": "tumor mass",
                                "requirement": {
                                    "requirement_type": "amenability to core needle biopsy",
                                    "expected_value": true
                                }
                            }
                        ]
                    },
                    {
                        "condition": {
                            "exact_snippets": "Adequate Archival Tissue required for patients that will take part in the dose escalation cohorts",
                            "criterion": "archival tissue",
                            "requirement": {
                                "requirement_type": "requirement for patients that will take part in the dose escalation cohorts",
                                "expected_value": true
                            }
                        },
                        "then_criteria": {
                            "exact_snippets": "Adequate Archival Tissue required for patients that will take part in the dose escalation cohorts",
                            "criterion": "archival tissue",
                            "requirement": {
                                "requirement_type": "adequacy",
                                "expected_value": true
                            }
                        },
                        "else_criteria": null
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. Dose expansion subjects must have at least one tumor mass amenable to core needle biopsy.",
                "criterions": [
                    {
                        "exact_snippets": "Dose expansion subjects must have at least one tumor mass amenable to core needle biopsy.",
                        "criterion": "tumor mass",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "mass"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Dose expansion subjects must have at least one tumor mass amenable to core needle biopsy.",
                        "criterion": "tumor mass",
                        "requirement": {
                            "requirement_type": "amenability to core needle biopsy",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Dose expansion subjects must have at least one tumor mass amenable to core needle biopsy.",
                        "criterion": "tumor mass",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "mass"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Dose expansion subjects must have at least one tumor mass amenable to core needle biopsy.",
                        "criterion": "tumor mass",
                        "requirement": {
                            "requirement_type": "amenability to core needle biopsy",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Refractory or intolerant to established standard of care.",
                "criterions": [
                    {
                        "exact_snippets": "Refractory or intolerant to established standard of care.",
                        "criterion": "response to established standard of care",
                        "requirement": {
                            "requirement_type": "refractory or intolerant",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Refractory or intolerant to established standard of care.",
                        "criterion": "response to established standard of care",
                        "requirement": {
                            "requirement_type": "refractory or intolerant",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Inclusion Criteria",
                "criterions": []
            },
            "logical_structure": {
                "and_criteria": []
            }
        },
        {
            "identified_line": {
                "line": "9. Ability to understand and the willingness to sign a written informed protocol specific consent.",
                "criterions": [
                    {
                        "exact_snippets": "Ability to understand",
                        "criterion": "cognitive ability",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "willingness to sign a written informed protocol specific consent",
                        "criterion": "willingness to provide informed consent",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Ability to understand",
                        "criterion": "cognitive ability",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "willingness to sign a written informed protocol specific consent",
                        "criterion": "willingness to provide informed consent",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "7. Subject has recovered to CTCAE Grade 1 or better from all adverse events associated with prior therapy or surgery. Pre-existing motor or sensory neurologic pathology or symptoms must be recovered to CTCAE Grade 2 or better.",
                "criterions": [
                    {
                        "exact_snippets": "Subject has recovered to CTCAE Grade 1 or better from all adverse events associated with prior therapy or surgery",
                        "criterion": "recovery from adverse events associated with prior therapy or surgery",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "CTCAE Grade"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Pre-existing motor or sensory neurologic pathology or symptoms must be recovered to CTCAE Grade 2 or better",
                        "criterion": "recovery from pre-existing motor or sensory neurologic pathology or symptoms",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "CTCAE Grade"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Subject has recovered to CTCAE Grade 1 or better from all adverse events associated with prior therapy or surgery",
                        "criterion": "recovery from adverse events associated with prior therapy or surgery",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "CTCAE Grade"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Pre-existing motor or sensory neurologic pathology or symptoms must be recovered to CTCAE Grade 2 or better",
                        "criterion": "recovery from pre-existing motor or sensory neurologic pathology or symptoms",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "CTCAE Grade"
                            }
                        }
                    }
                ]
            }
        }
    ],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "identified_line": {
                "line": "4. Brain metastases unless treated with curative intent (gamma knife or surgical resection) and without evidence of progression for ≥ 2 months.",
                "criterions": [
                    {
                        "exact_snippets": "Brain metastases unless treated with curative intent (gamma knife or surgical resection)",
                        "criterion": "brain metastases",
                        "requirement": {
                            "requirement_type": "treatment",
                            "expected_value": [
                                "curative intent (gamma knife or surgical resection)"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "without evidence of progression for ≥ 2 months",
                        "criterion": "brain metastases progression",
                        "requirement": {
                            "requirement_type": "progression",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "without evidence of progression for ≥ 2 months",
                        "criterion": "brain metastases progression",
                        "requirement": {
                            "requirement_type": "duration without progression",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "months"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "11. Patients diagnosed with Wolff-Parkinson-White Syndrome or electrocardiographic (ECG) pattern. Other cardiac conditions including: Previous MI with evidence of residual electrographic pattern consisted with bradycardia/heart block. Atrio-ventricular (AV) heart block (currently ongoing). History of ventricular fibrillation. Sick Sinus Syndrome or Sinus bradycardia thought to be caused by sinus node disease, unless effectively treated. Heart failure associated with preserved left ventricular ejection fraction, including constructive pericarditis, restrictive cardiomyopathy, and Amyloid heart muscle disease.",
                "criterions": [
                    {
                        "exact_snippets": "Patients diagnosed with Wolff-Parkinson-White Syndrome",
                        "criterion": "Wolff-Parkinson-White Syndrome",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "electrocardiographic (ECG) pattern",
                        "criterion": "abnormal electrocardiographic (ECG) pattern",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previous MI with evidence of residual electrographic pattern consisted with bradycardia/heart block",
                        "criterion": "previous myocardial infarction with residual electrographic pattern",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previous MI with evidence of residual electrographic pattern consisted with bradycardia/heart block",
                        "criterion": "previous myocardial infarction with residual electrographic pattern",
                        "requirement": {
                            "requirement_type": "residual electrographic pattern",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previous MI with evidence of residual electrographic pattern consisted with bradycardia/heart block",
                        "criterion": "previous myocardial infarction with residual electrographic pattern",
                        "requirement": {
                            "requirement_type": "associated conditions",
                            "expected_value": [
                                "bradycardia",
                                "heart block"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "Atrio-ventricular (AV) heart block (currently ongoing)",
                        "criterion": "atrio-ventricular (AV) heart block",
                        "requirement": {
                            "requirement_type": "current status",
                            "expected_value": "ongoing"
                        }
                    },
                    {
                        "exact_snippets": "History of ventricular fibrillation",
                        "criterion": "ventricular fibrillation",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Sick Sinus Syndrome or Sinus bradycardia thought to be caused by sinus node disease, unless effectively treated",
                        "criterion": "Sick Sinus Syndrome or Sinus bradycardia due to sinus node disease",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Sick Sinus Syndrome or Sinus bradycardia thought to be caused by sinus node disease, unless effectively treated",
                        "criterion": "Sick Sinus Syndrome or Sinus bradycardia due to sinus node disease",
                        "requirement": {
                            "requirement_type": "effectively treated",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Heart failure associated with preserved left ventricular ejection fraction, including constructive pericarditis, restrictive cardiomyopathy, and Amyloid heart muscle disease",
                        "criterion": "heart failure with preserved left ventricular ejection fraction",
                        "requirement": {
                            "requirement_type": "association",
                            "expected_value": [
                                "constructive pericarditis",
                                "restrictive cardiomyopathy",
                                "Amyloid heart muscle disease"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "2. Known history of other malignancy unless having undergone curative intent therapy without evidence of that disease for ≥ 3 years except cutaneous squamous cell and basal cell skin cancer, superficial bladder cancer, in situ cervical cancer or other in situ cancers are allowed if definitively resected.",
                "criterions": [
                    {
                        "exact_snippets": "Known history of other malignancy unless having undergone curative intent therapy without evidence of that disease for ≥ 3 years",
                        "criterion": "history of other malignancy",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Known history of other malignancy unless having undergone curative intent therapy without evidence of that disease for ≥ 3 years",
                        "criterion": "history of other malignancy",
                        "requirement": {
                            "requirement_type": "curative intent therapy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Known history of other malignancy unless having undergone curative intent therapy without evidence of that disease for ≥ 3 years",
                        "criterion": "history of other malignancy",
                        "requirement": {
                            "requirement_type": "evidence of disease-free interval",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "years"
                            }
                        }
                    },
                    {
                        "exact_snippets": "except cutaneous squamous cell and basal cell skin cancer, superficial bladder cancer, in situ cervical cancer or other in situ cancers are allowed if definitively resected",
                        "criterion": "history of specific cancers (cutaneous squamous cell and basal cell skin cancer, superficial bladder cancer, in situ cervical cancer, other in situ cancers)",
                        "requirement": {
                            "requirement_type": "definitive resection",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Known history of other malignancy unless having undergone curative intent therapy without evidence of that disease for \u001e 3 years",
                                "criterion": "history of other malignancy",
                                "requirement": {
                                    "requirement_type": "history",
                                    "expected_value": true
                                }
                            },
                            {
                                "not_criteria": {
                                    "and_criteria": [
                                        {
                                            "exact_snippets": "Known history of other malignancy unless having undergone curative intent therapy without evidence of that disease for \u001e 3 years",
                                            "criterion": "history of other malignancy",
                                            "requirement": {
                                                "requirement_type": "curative intent therapy",
                                                "expected_value": true
                                            }
                                        },
                                        {
                                            "exact_snippets": "Known history of other malignancy unless having undergone curative intent therapy without evidence of that disease for \u001e 3 years",
                                            "criterion": "history of other malignancy",
                                            "requirement": {
                                                "requirement_type": "evidence of disease-free interval",
                                                "expected_value": {
                                                    "operator": ">=",
                                                    "value": 3,
                                                    "unit": "years"
                                                }
                                            }
                                        }
                                    ]
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "except cutaneous squamous cell and basal cell skin cancer, superficial bladder cancer, in situ cervical cancer or other in situ cancers are allowed if definitively resected",
                                "criterion": "history of specific cancers (cutaneous squamous cell and basal cell skin cancer, superficial bladder cancer, in situ cervical cancer, other in situ cancers)",
                                "requirement": {
                                    "requirement_type": "definitive resection",
                                    "expected_value": true
                                }
                            },
                            {
                                "not_criteria": {
                                    "exact_snippets": "except cutaneous squamous cell and basal cell skin cancer, superficial bladder cancer, in situ cervical cancer or other in situ cancers are allowed if definitively resected",
                                    "criterion": "history of specific cancers (cutaneous squamous cell and basal cell skin cancer, superficial bladder cancer, in situ cervical cancer, other in situ cancers)",
                                    "requirement": {
                                        "requirement_type": "definitive resection",
                                        "expected_value": true
                                    }
                                }
                            }
                        ]
                    }
                ]
            }
        }
    ],
    "failed_miscellaneous": [
        {
            "identified_line": {
                "line": "6. Normal organ and marrow function: absolute granulocyte count ≥1,000/mm3, absolute lymphocyte count ≥400/mm3, platelets ≥100,000/mm3, total bilirubin ≤ institutional upper normal limit, AST/ASL ≤2x institutional upper limit of normal, GFR >60 mL/min/1.73 m2 and creatinine <1.5 mg/dL.",
                "criterions": [
                    {
                        "exact_snippets": "absolute granulocyte count ≥1,000/mm3",
                        "criterion": "absolute granulocyte count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1000,
                                "unit": "mm3"
                            }
                        }
                    },
                    {
                        "exact_snippets": "absolute lymphocyte count ≥400/mm3",
                        "criterion": "absolute lymphocyte count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 400,
                                "unit": "mm3"
                            }
                        }
                    },
                    {
                        "exact_snippets": "platelets ≥100,000/mm3",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100000,
                                "unit": "mm3"
                            }
                        }
                    },
                    {
                        "exact_snippets": "total bilirubin ≤ institutional upper normal limit",
                        "criterion": "total bilirubin",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "institutional upper normal limit"
                            }
                        }
                    },
                    {
                        "exact_snippets": "AST/ASL ≤2x institutional upper limit of normal",
                        "criterion": "AST/ASL",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "institutional upper limit of normal"
                            }
                        }
                    },
                    {
                        "exact_snippets": "GFR >60 mL/min/1.73 m2",
                        "criterion": "glomerular filtration rate (GFR)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 60,
                                "unit": "mL/min/1.73 m2"
                            }
                        }
                    },
                    {
                        "exact_snippets": "creatinine <1.5 mg/dL",
                        "criterion": "creatinine",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "mg/dL"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "absolute granulocyte count \u001e=1,000/mm3",
                        "criterion": "absolute granulocyte count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1000,
                                "unit": "mm3"
                            }
                        }
                    },
                    {
                        "exact_snippets": "absolute lymphocyte count \u001e=400/mm3",
                        "criterion": "absolute lymphocyte count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 400,
                                "unit": "mm3"
                            }
                        }
                    },
                    {
                        "exact_snippets": "platelets \u001e=100,000/mm3",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100000,
                                "unit": "mm3"
                            }
                        }
                    },
                    {
                        "exact_snippets": "total bilirubin \u001e institutional upper normal limit",
                        "criterion": "total bilirubin",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "institutional upper normal limit"
                            }
                        }
                    },
                    {
                        "exact_snippets": "AST/ASL \u001e2x institutional upper limit of normal",
                        "criterion": "AST/ASL",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "institutional upper limit of normal"
                            }
                        }
                    },
                    {
                        "exact_snippets": "GFR >60 mL/min/1.73 m2",
                        "criterion": "glomerular filtration rate (GFR)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 60,
                                "unit": "mL/min/1.73 m2"
                            }
                        }
                    },
                    {
                        "exact_snippets": "creatinine <1.5 mg/dL",
                        "criterion": "creatinine",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "mg/dL"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "1. Subject ≥18 years with histologically confirmed solid tumor.",
                "criterions": [
                    {
                        "exact_snippets": "Subject ≥18 years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    },
                    {
                        "exact_snippets": "histologically confirmed solid tumor",
                        "criterion": "solid tumor",
                        "requirement": {
                            "requirement_type": "confirmation method",
                            "expected_value": "histologically confirmed"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Subject \u001e18 years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    },
                    {
                        "exact_snippets": "histologically confirmed solid tumor",
                        "criterion": "solid tumor",
                        "requirement": {
                            "requirement_type": "confirmation method",
                            "expected_value": "histologically confirmed"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "8. If female of childbearing potential, has a negative urine or serum pregnancy test. If the urine test is positive or cannot be confirmed as negative, a negative serum test will then be required for study entry.",
                "criterions": [
                    {
                        "exact_snippets": "If female of childbearing potential",
                        "criterion": "female of childbearing potential",
                        "requirement": {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        }
                    },
                    {
                        "exact_snippets": "If female of childbearing potential",
                        "criterion": "female of childbearing potential",
                        "requirement": {
                            "requirement_type": "childbearing potential",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "has a negative urine or serum pregnancy test. If the urine test is positive or cannot be confirmed as negative, a negative serum test will then be required for study entry.",
                        "criterion": "pregnancy test result",
                        "requirement": {
                            "requirement_type": "test type",
                            "expected_value": [
                                "urine",
                                "serum"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "has a negative urine or serum pregnancy test. If the urine test is positive or cannot be confirmed as negative, a negative serum test will then be required for study entry.",
                        "criterion": "pregnancy test result",
                        "requirement": {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "5. ECOG performance status (PS) = 0-2, or Karnofsky PS ≥60%, or Lansky PS ≥60%.",
                "criterions": [
                    {
                        "exact_snippets": "ECOG performance status (PS) = 0-2",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "Karnofsky PS ≥60%",
                        "criterion": "Karnofsky performance status",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "%"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Lansky PS ≥60%",
                        "criterion": "Lansky performance status",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "%"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "ECOG performance status (PS) = 0-2",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "Karnofsky PS \u001e60%",
                        "criterion": "Karnofsky performance status",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "%"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Lansky PS \u001e60%",
                        "criterion": "Lansky performance status",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "%"
                            }
                        }
                    }
                ]
            }
        }
    ]
}